Resolution of the XII All-Russian Conference with International Participation "Topical Issues of Preclinical and Clinical Research of Medicinal Products and Clinical Trials of Medical Devices", April 24-25, 2025, Saint-Petersburg
E. E. Zvartau,
A. S. Kolbin,
E. V. Verbitskaya,
E. M. Krupitsky,
A. O. Kibitov,
M. A. Zaitseva,
A. D. Durnev,
A. K. Zhanataev https://doi.org/10.37489/2782-3784-myrwd-077
EDN: VWCRUZ
Abstract
On April 24-25, 2025, the XII All-Russian Conference with international participation «Topical issues of preclinical and clinical studies of drugs and clinical trials of medical devices» was organized and held. The topic of the conference brought together leading experts in the field of preclinical and clinical research. Participants’ prospects for the development of toxicology, preclinical studies of specific activity and translational models, programs for the preclinical development of biomedical cell products, experience in the clinical application of medical programs using artificial intelligence, a personalized approach to prevention and therapy in psychiatry and narcology, pharmacovigilance, the use of real clinical practice data, regulatory issues of clinical trials in pediatrics, data management, biomedical statistics, and mathematical modeling in preclinical and clinical studies. Following the conference, a Resolution was developed, the text of which we invite you to familiarize yourself with.
Keywords
clinical research,
preclinical research,
clinical trials,
medical devices,
biomedical cell products,
real clinical practice,
biomedical statistics,
data management,
mathematical modeling,
pharmacovigilance,
artificial intelligence,
biomedical research
Supporting agencies: The work was carried out without sponsorship
About the Authors
E. E. Zvartau
First Saint Petersburg State Medical University named after Academician I.P. Pavlov
Russian Federation
Competing Interests:
Russian Federation
Edvin E. Zvartau, Dr. Sci. (Med.), Professor, Head of the Department
Department of Pharmacology
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
A. S. Kolbin
First Saint Petersburg State Medical University named after Academician I.P. Pavlov
Russian Federation
Competing Interests:
Russian Federation
Alexey S. Kolbin, Dr. Sci. (Med.), Professor, Head of the Department
Department of Clinical Pharmacology and Evidence-Based Medicine
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
E. V. Verbitskaya
First Saint Petersburg State Medical University named after Academician I.P. Pavlov
Russian Federation
Competing Interests:
Russian Federation
Elena V. Verbitskaya, Dr. Sci. (Biol.), Associate Professor, Head of the Department
Department of Clinical Pharmacology and Evidence-Based Medicine; Scientific Research Department; Department of Biomedical Statistics
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
E. M. Krupitsky
First Saint Petersburg State Medical University named after Academician I.P. Pavlov; National Medical Research Center of Psychiatry and Neurology named after V.M. Bekhterev
Russian Federation
Competing Interests:
Russian Federation
Evgeny M. Krupitsky, Dr. Sci. (Med.), Professor, Deputy Director for Science, Director of the Institute
Institute of Pharmacology named after A. V. Waldman
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
A. O. Kibitov
First Saint Petersburg State Medical University named after Academician I.P. Pavlov; National Medical Research Center of Psychiatry and Neurology named after V.M. Bekhterev
Russian Federation
Competing Interests:
Russian Federation
Alexsandr O. Kibitov, Dr. Sci. (Med.), Leading Researcher
Institute of Translational Psychiatry
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
M. A. Zaitseva
National Medical Research Center of Oncology named after N.N. Petrov
Russian Federation
Competing Interests:
Russian Federation
Maria A. Zaitseva, Cand. Sci. (Med.), National Industry GLP Inspector, Senior Researcher
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
A. D. Durnev
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation
Competing Interests:
Russian Federation
Andrey D. Durnev, Dr. Sci. (Med.), Academician of the Russian Academy of Sciences, Chief Researcher
Department of Drug Toxicology
Moscow
Competing Interests:
The authors declare no conflict of interest
A. K. Zhanataev
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies
Russian Federation
Competing Interests:
Russian Federation
Aliy K. Zhanataev, Cand. Sci. (Biol.), Head of the Laboratory
Department of Drug Toxicology; Laboratory of Genetic and Reproductive Toxicology
Moscow
Competing Interests:
The authors declare no conflict of interest
Review
For citations:
Zvartau E.E., Kolbin A.S., Verbitskaya E.V., Krupitsky E.M., Kibitov A.O., Zaitseva M.A., Durnev A.D., Zhanataev A.K. Resolution of the XII All-Russian Conference with International Participation "Topical Issues of Preclinical and Clinical Research of Medicinal Products and Clinical Trials of Medical Devices", April 24-25, 2025, Saint-Petersburg. Real-World Data & Evidence. 2025;5(2):101-105. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-077. EDN: VWCRUZ
Views:
64
Email this article 
Post a Comment 